Literature DB >> 2048048

Bleeding/bruising symptomatology in children with and without bleeding disorders.

B Nosek-Cenkowska1, M S Cheang, N J Pizzi, E D Israels, J M Gerrard.   

Abstract

A questionnaire, designed to assess bleeding/bruising tendencies, was administered to 251 otherwise healthy children undergoing a tonsillectomy and/or adenoidectomy. 23 children with excessive bleeding during or after the operation, with a long bleeding time or who reported taking aspirin recently were excluded, to give a population of 228 non-bleeders. For comparative purposes, 31 patients with bleeding disorders (von Willebrand's disease and/or platelet function defects) were studied. A considerable proportion of "non-bleeding" children reported easy bruising (24%), had bruises at least once a week (36%) and suffered from nosebleeds (39%). The respective frequencies (67%, 68% and 69%) for children with bleeding disorders were significantly higher. Occurrence of bruises usually on more than one part of the body, frequent large bruises or hematomas were rare in "non-bleeders" (4.9%, 3.5% and 2.7% respectively), but more common in "bleeders" (38.5%, 29.6% and 21.7% respectively).

Entities:  

Mesh:

Year:  1991        PMID: 2048048

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Personal practice: An approach to investigation of easy bruising.

Authors:  A Vora; M Makris
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

2.  Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults.

Authors:  A C Mauer; N A Khazanov; N Levenkova; S Tian; E M Barbour; C Khalida; J N Tobin; B S Coller
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

Review 3.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

4.  Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease.

Authors:  Karon Abe; Brandi Dupervil; Sarah H O'Brien; Meredith Oakley; Roshni Kulkarni; Joan Cox Gill; Vanessa Byams; Michael J Soucie
Journal:  Am J Hematol       Date:  2019-10-29       Impact factor: 13.265

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.